Annette Wysocki, PhD
Position: Professor, Division of Cardiothoracic Surgery
Office Phone: 601-815-4267
Office Fax: 601-984-5127
E-mail: awysocki@umsmed.edu
Research Interests: Wound Healing, Extracellular Matrix, Matrix Metalloproteinases, Bacterial proteases
Societies: Fellow American Academy ofNursing, American Association for the Advancement of Science, American Society for Cell Biology, New York Academy of Sciences, Society for Investigative Dermatology, Wound Healing Society
Bibliography:
1. Wysocki, A., Mustoe, T., Schultz, G. (In press). Skin, Molecular Cell Biologyof. Encyclopedia of Molecular Biology and Molecular Medicine.
2. Schultz G.S., Ladwig, G., Wysocki, A.B. (2005). Extracellular matrix: Reviewof its roles in acute and chronic wounds. World Wide Wounds http://www.worldwidewounds.com/2005/august/Schultz...
/Extrace-Matric-Acute-Chronic-Wounds.html.
3. Wysocki, A.B., Bookbinder M. (2005). Implementing clinical practice changes:A practical approach. Home Health Care Management & Practice, 17:164-174.
4. Wysocki, A.B. (2002). Evaluating and managing open skin wounds: Colonizationversus infection. AAACN Clinical Issues: Advanced Practice in Acute and CriticalCare: Emerging Infections, 13:382-397.
5. Wysocki, A.B. (2001) Elaboration D’Un Protocole De Recherche Clinique (Developinga Clinical Research Protocol). Journal des Plaies et Cicatrisations, 6:6-11.
6. Wysocki, A.B., Kusakabe, A.O., Chang, S., Tuan, T.-L. (1999). Temporalexpression of urokinase plasminogen activator, plasminogen activator inhibitorand gelatinase-B in chronic chronic wound fluid switches from a chronic toacute wound profile with progression to healing. Wound Repair and Regeneration,7:154-165.
7. Wysocki, A.B. (1999). Skin anatomy, physiology, and pathophysiology. NursingClinics of North America, 34(4):777-797.
8. Wysocki, A.B. (1998). Launching your research career through postdoctoraltraining opportunities. Nursing Research, 47(3):127-128.
9. Gray, M., Wysocki, A.B. (1997). Bridging the gap from bench to bedsidein wound care. Journal of WOCN, 24(2):62-65.
10. Wysocki, A.B. (1997). Wound measurement - reply. International Journalof Dermatology, 36(5):399.
11. Wysocki, A.B. (1996). Wound fluids and the pathogenesis of chronic wounds.Journal of WOCN, 23(6):283-290.
12. Chang J. C., Wysocki, A., Tchou-Wong, K-M., Moskowitz, N., Zhang, Y.,and Rom W.N. (1996). Effect of Mycobacterium tuberculosis and its componentson macrophage release of matrix metalloproteinases. Thorax, 51(3), 306-311.(42 citations)
13. Wysocki, A. B. (1996). The effect of intermittent noise exposure on excisionalwound healing. Advances in Wound Care, 9(1), 35-39.
14. Wysocki, A. B. (1996). Wound measurement: A review. International Journalof Dermatology, 35(2),82-91.
15. Wysocki, A. B. (1995). A review of the skin and its appendages. Advancesin Wound Care, 8(2), 53-70. [published erratum appears in Advances in WoundCare, 8(4),8.]
16. *Wysocki, A. B., Staiano-Coico, L., and Grinnell, F. (1993). Wound fluidfrom chronic leg ulcers contains elevated levels of metalloproteinases MMP-2and MMP-9. Journal of Investigative Dermatology, 101(1), 64-68. (*Over 167citations)
17. Wysocki, A. B. (1992). Fibronectin in acute and chronic wounds. Journalof ET Nursing, 19(5), 166-170.
18. *Grinnell, F., Ho, C-H., and Wysocki, A. B. (1992). Degradation of fibronectinand vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting,and cell adhesion assays. Journal of Investigative Dermatology, 98(4), 410-416.(* 98 citations)
19. Wysocki, A. B. and Grinnell, F. (1990). Fibronectin profiles in normaland chronic wound fluid. Laboratory Investigation, 63(6), 825-831. (37 citations)
20. Thomas, A. C. and Wysocki, A. B. (1990) The healing wound: A comparisonof three clinically useful methods of measurement. Decubitus, 3(1), 18-20,24-25.
21. Wysocki, A. B. (1989). Surgical wound healing: A review for perioperativenurses. AORN Journal, 49(2), 502-518.
22. Wysocki, A., Baxter, C. R., Bergstresser, P. R., Grinnell, F., Horowitz,M. S., and Horowitz, B. (1988). Topical fibronectin therapy for treatmentof a patient with chronic stasis ulcers. Archives of Dermatology, 124(2),175-177.
23. Kim, N.H., Wysocki, A.B., Bovik, A.C. and Diller, K.R. ( 1987). A microcomputerbased vision system for area measurement. Computers in Biology and Medicine,17(3), 173-183.
1. Wysocki, A., Mustoe, T., Schultz, G. (In press). Skin, Molecular Cell Biologyof. Encyclopedia of Molecular Biology and Molecular Medicine.
2. Schultz G.S., Ladwig, G., Wysocki, A.B. (2005). Extracellular matrix: Reviewof its roles in acute and chronic wounds. World Wide Wounds http://www.worldwidewounds.com/2005/august/Schultz...
/Extrace-Matric-Acute-Chronic-Wounds.html.
3. Wysocki, A.B., Bookbinder M. (2005). Implementing clinical practice changes:A practical approach. Home Health Care Management & Practice, 17:164-174.
4. Wysocki, A.B. (2002). Evaluating and managing open skin wounds: Colonizationversus infection. AAACN Clinical Issues: Advanced Practice in Acute and CriticalCare: Emerging Infections, 13:382-397.
5. Wysocki, A.B. (2001) Elaboration D’Un Protocole De Recherche Clinique (Developinga Clinical Research Protocol). Journal des Plaies et Cicatrisations, 6:6-11.
6. Wysocki, A.B., Kusakabe, A.O., Chang, S., Tuan, T.-L. (1999). Temporalexpression of urokinase plasminogen activator, plasminogen activator inhibitorand gelatinase-B in chronic chronic wound fluid switches from a chronic toacute wound profile with progression to healing. Wound Repair and Regeneration,7:154-165.
7. Wysocki, A.B. (1999). Skin anatomy, physiology, and pathophysiology. NursingClinics of North America, 34(4):777-797.
8. Wysocki, A.B. (1998). Launching your research career through postdoctoraltraining opportunities. Nursing Research, 47(3):127-128.
9. Gray, M., Wysocki, A.B. (1997). Bridging the gap from bench to bedsidein wound care. Journal of WOCN, 24(2):62-65.
10. Wysocki, A.B. (1997). Wound measurement - reply. International Journalof Dermatology, 36(5):399.
11. Wysocki, A.B. (1996). Wound fluids and the pathogenesis of chronic wounds.Journal of WOCN, 23(6):283-290.
12. Chang J. C., Wysocki, A., Tchou-Wong, K-M., Moskowitz, N., Zhang, Y.,and Rom W.N. (1996). Effect of Mycobacterium tuberculosis and its componentson macrophage release of matrix metalloproteinases. Thorax, 51(3), 306-311.(42 citations)
13. Wysocki, A. B. (1996). The effect of intermittent noise exposure on excisionalwound healing. Advances in Wound Care, 9(1), 35-39.
14. Wysocki, A. B. (1996). Wound measurement: A review. International Journalof Dermatology, 35(2),82-91.
15. Wysocki, A. B. (1995). A review of the skin and its appendages. Advancesin Wound Care, 8(2), 53-70. [published erratum appears in Advances in WoundCare, 8(4),8.]
16. *Wysocki, A. B., Staiano-Coico, L., and Grinnell, F. (1993). Wound fluidfrom chronic leg ulcers contains elevated levels of metalloproteinases MMP-2and MMP-9. Journal of Investigative Dermatology, 101(1), 64-68. (*Over 167citations)
17. Wysocki, A. B. (1992). Fibronectin in acute and chronic wounds. Journalof ET Nursing, 19(5), 166-170.
18. *Grinnell, F., Ho, C-H., and Wysocki, A. B. (1992). Degradation of fibronectinand vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting,and cell adhesion assays. Journal of Investigative Dermatology, 98(4), 410-416.(* 98 citations)
19. Wysocki, A. B. and Grinnell, F. (1990). Fibronectin profiles in normaland chronic wound fluid. Laboratory Investigation, 63(6), 825-831. (37 citations)
20. Thomas, A. C. and Wysocki, A. B. (1990) The healing wound: A comparisonof three clinically useful methods of measurement. Decubitus, 3(1), 18-20,24-25.
21. Wysocki, A. B. (1989). Surgical wound healing: A review for perioperativenurses. AORN Journal, 49(2), 502-518.
22. Wysocki, A., Baxter, C. R., Bergstresser, P. R., Grinnell, F., Horowitz,M. S., and Horowitz, B. (1988). Topical fibronectin therapy for treatmentof a patient with chronic stasis ulcers. Archives of Dermatology, 124(2),175-177.
23. Kim, N.H., Wysocki, A.B., Bovik, A.C. and Diller, K.R. ( 1987). A microcomputerbased vision system for area measurement. Computers in Biology and Medicine,17(3), 173-183.